Neurocrine Biosciences, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Diego, CA
US patents127
SAM.gov UEIGMQSH4CZ7EC9
CAGE code5H9C3
Incorporated inDE
LEI549300FECER0XBN49756
Open positions
Openings read from Neurocrine Biosciences, INC.’s own job board on Workday, last checked NOV 13, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Associate Scientist, Animal CareUS CA San Diego · posted NOV 13, 2026
- Vivarium Tech IIUS CA San Diego · posted NOV 13, 2026
- Clinical Trials ManagerUS CA San Diego · posted NOV 13, 2026
- Director, Medical CommunicationsUS CA San Diego One Paseo · posted NOV 12, 2026
- Associate Director, Medical CommunicationsUS CA San Diego One Paseo · posted NOV 12, 2026
- Sr. Director, Patient Support ServicesUS CA San Diego One Paseo · posted NOV 12, 2026
- Sr. Analyst, Field OperationsUS CA San Diego One Paseo · posted NOV 12, 2026
- Sr. Manager, Clinical Data ManagementUS CA San Diego · posted NOV 12, 2026
- Scientist II – Endocrinology DiscoveryUS CA San Diego · posted NOV 11, 2026
- Sr. Director, Global Drug Safety MDUS CA San Diego · posted NOV 11, 2026
142 more on the company’s board
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
127 US patents granted 1995–2025, 35 of them in the five years to SEP 2025.
Pharmaceuticals 89Organic fine chemistry 38
- GPR52 modulators and methods of useUS 12,421,193 · granted SEP 23, 2025
- CRF receptor antagonists and methods of useUS 12,383,536 · granted AUG 12, 2025
- Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amineUS 12,128,033 · granted OCT 29, 2024
- Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosisUS 12,102,637 · granted OCT 1, 2024
- Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosisUS 12,083,227 · granted SEP 10, 2024
Newest 5 shown · Granted to Neurocrine Biosciences, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neurocrine Biosciences, INC. | San Diego | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.

